Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation
To investigate the outcomes of autologous stem cell transplantation (ASCT) for patients with aggressive peripheral T-cell lymphoma (PTCLs) in advanced stage. The clinical data of 25 patients in complete remission (CR) with aggressive PTCLs received ASCT from May 1997 to June 2013 were retrospectivel...
Gespeichert in:
| Veröffentlicht in: | Zhōnghuá xuèyèxué zázhì 2015-06, Vol.36 (6), p.455 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | chi |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 6 |
| container_start_page | 455 |
| container_title | Zhōnghuá xuèyèxué zázhì |
| container_volume | 36 |
| creator | Zou, Dehui Huang, Wenyang Liu, Hong Fu, Mingwei Li, Zengjun Sui, Weiwei Qi, Junyuan Zhao, Yaozhong Ru, Kun Han, Mingzhe Qiu, Lugui |
| description | To investigate the outcomes of autologous stem cell transplantation (ASCT) for patients with aggressive peripheral T-cell lymphoma (PTCLs) in advanced stage.
The clinical data of 25 patients in complete remission (CR) with aggressive PTCLs received ASCT from May 1997 to June 2013 were retrospectively analyzed.
① Of the 25 cases, 16 were unspecified PTCL (PTCL-U), 4 with angioimmunoblastic T cell lymphoma (AITL), 3 with anaplastic large cell lymphoma (ALCL) and 2 with hepatosplenic T cell lymphoma (HSTL), with a median age of 30(12-54) years old. Ratio of male to female is 16∶9. The distribution of stages was 8 cases with stage Ⅲ and 17 patients with stage Ⅳ. Nine patients presented with bone marrow involvement. Before ASCT, 18 patients were in CR1 and 7 patients were in CR2. ②Two patients with HSTL in stage ⅣB and IPI score 4/5 in CR1 relapsed and died within 12 months after ASCT. At a median follow-up of 38 (range 14-110) months, the estimated 3-year probability of PFS and OS for the other 23 patients was (6 |
| doi_str_mv | 10.3760/cma.j.issn.0253-2727.2015.06.002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1694965127</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1694965127</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-93469aae5d8cd9a0404514f3748860dca49ed61dc8764a45126c9e12f4a235243</originalsourceid><addsrcrecordid>eNo9UMlOwzAQ9QFEK-gvIB97SfAWJzmiik2qxKWco2kySY0cJ8RuUb-CX8bQwmk081YNIUvOUplrdlf3kL6nxnuXMpHJROQiTwXjWcp0ypi4IPP_-4wsvDdblnGpCynZFZkJzaViLJ-Tr5U1ztRgKTiwR288HVoqMjpCMOiCp58m7Ch03YTR5YB0xMmMO5yiZJPUaC21x37cDT1Q4yg0B3A1NtQH6JCGCSHE7WSyD4MdumHvI4o9_RWHCZwfLbgQAwd3Qy5bsB4X53lN3h4fNqvnZP369LK6XycjFzokpVS6BMCsKeqmBKaYyrhqZa6KQrOmBlVio3lTF7lWEDGh6xK5aBUImQklr8ny5DtOw8cefah6438KgcNYsOK6VKWOujxSb8_U_bbHphon08N0rP6eKL8B1CV5ug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1694965127</pqid></control><display><type>article</type><title>Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation</title><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ）</source><source>PubMed</source><creator>Zou, Dehui ; Huang, Wenyang ; Liu, Hong ; Fu, Mingwei ; Li, Zengjun ; Sui, Weiwei ; Qi, Junyuan ; Zhao, Yaozhong ; Ru, Kun ; Han, Mingzhe ; Qiu, Lugui</creator><creatorcontrib>Zou, Dehui ; Huang, Wenyang ; Liu, Hong ; Fu, Mingwei ; Li, Zengjun ; Sui, Weiwei ; Qi, Junyuan ; Zhao, Yaozhong ; Ru, Kun ; Han, Mingzhe ; Qiu, Lugui</creatorcontrib><description>To investigate the outcomes of autologous stem cell transplantation (ASCT) for patients with aggressive peripheral T-cell lymphoma (PTCLs) in advanced stage.
The clinical data of 25 patients in complete remission (CR) with aggressive PTCLs received ASCT from May 1997 to June 2013 were retrospectively analyzed.
① Of the 25 cases, 16 were unspecified PTCL (PTCL-U), 4 with angioimmunoblastic T cell lymphoma (AITL), 3 with anaplastic large cell lymphoma (ALCL) and 2 with hepatosplenic T cell lymphoma (HSTL), with a median age of 30(12-54) years old. Ratio of male to female is 16∶9. The distribution of stages was 8 cases with stage Ⅲ and 17 patients with stage Ⅳ. Nine patients presented with bone marrow involvement. Before ASCT, 18 patients were in CR1 and 7 patients were in CR2. ②Two patients with HSTL in stage ⅣB and IPI score 4/5 in CR1 relapsed and died within 12 months after ASCT. At a median follow-up of 38 (range 14-110) months, the estimated 3-year probability of PFS and OS for the other 23 patients was (6</description><identifier>ISSN: 0253-2727</identifier><identifier>DOI: 10.3760/cma.j.issn.0253-2727.2015.06.002</identifier><identifier>PMID: 26134007</identifier><language>chi</language><publisher>China</publisher><subject>Adolescent ; Adult ; Child ; Female ; Hematopoietic Stem Cell Transplantation ; Humans ; Lymphoma, Large-Cell, Anaplastic ; Lymphoma, T-Cell, Peripheral ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Remission Induction ; Retrospective Studies ; Transplantation, Autologous ; Young Adult</subject><ispartof>Zhōnghuá xuèyèxué zázhì, 2015-06, Vol.36 (6), p.455</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26134007$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zou, Dehui</creatorcontrib><creatorcontrib>Huang, Wenyang</creatorcontrib><creatorcontrib>Liu, Hong</creatorcontrib><creatorcontrib>Fu, Mingwei</creatorcontrib><creatorcontrib>Li, Zengjun</creatorcontrib><creatorcontrib>Sui, Weiwei</creatorcontrib><creatorcontrib>Qi, Junyuan</creatorcontrib><creatorcontrib>Zhao, Yaozhong</creatorcontrib><creatorcontrib>Ru, Kun</creatorcontrib><creatorcontrib>Han, Mingzhe</creatorcontrib><creatorcontrib>Qiu, Lugui</creatorcontrib><title>Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation</title><title>Zhōnghuá xuèyèxué zázhì</title><addtitle>Zhonghua Xue Ye Xue Za Zhi</addtitle><description>To investigate the outcomes of autologous stem cell transplantation (ASCT) for patients with aggressive peripheral T-cell lymphoma (PTCLs) in advanced stage.
The clinical data of 25 patients in complete remission (CR) with aggressive PTCLs received ASCT from May 1997 to June 2013 were retrospectively analyzed.
① Of the 25 cases, 16 were unspecified PTCL (PTCL-U), 4 with angioimmunoblastic T cell lymphoma (AITL), 3 with anaplastic large cell lymphoma (ALCL) and 2 with hepatosplenic T cell lymphoma (HSTL), with a median age of 30(12-54) years old. Ratio of male to female is 16∶9. The distribution of stages was 8 cases with stage Ⅲ and 17 patients with stage Ⅳ. Nine patients presented with bone marrow involvement. Before ASCT, 18 patients were in CR1 and 7 patients were in CR2. ②Two patients with HSTL in stage ⅣB and IPI score 4/5 in CR1 relapsed and died within 12 months after ASCT. At a median follow-up of 38 (range 14-110) months, the estimated 3-year probability of PFS and OS for the other 23 patients was (6</description><subject>Adolescent</subject><subject>Adult</subject><subject>Child</subject><subject>Female</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Humans</subject><subject>Lymphoma, Large-Cell, Anaplastic</subject><subject>Lymphoma, T-Cell, Peripheral</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>Remission Induction</subject><subject>Retrospective Studies</subject><subject>Transplantation, Autologous</subject><subject>Young Adult</subject><issn>0253-2727</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UMlOwzAQ9QFEK-gvIB97SfAWJzmiik2qxKWco2kySY0cJ8RuUb-CX8bQwmk081YNIUvOUplrdlf3kL6nxnuXMpHJROQiTwXjWcp0ypi4IPP_-4wsvDdblnGpCynZFZkJzaViLJ-Tr5U1ztRgKTiwR288HVoqMjpCMOiCp58m7Ch03YTR5YB0xMmMO5yiZJPUaC21x37cDT1Q4yg0B3A1NtQH6JCGCSHE7WSyD4MdumHvI4o9_RWHCZwfLbgQAwd3Qy5bsB4X53lN3h4fNqvnZP369LK6XycjFzokpVS6BMCsKeqmBKaYyrhqZa6KQrOmBlVio3lTF7lWEDGh6xK5aBUImQklr8ny5DtOw8cefah6438KgcNYsOK6VKWOujxSb8_U_bbHphon08N0rP6eKL8B1CV5ug</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>Zou, Dehui</creator><creator>Huang, Wenyang</creator><creator>Liu, Hong</creator><creator>Fu, Mingwei</creator><creator>Li, Zengjun</creator><creator>Sui, Weiwei</creator><creator>Qi, Junyuan</creator><creator>Zhao, Yaozhong</creator><creator>Ru, Kun</creator><creator>Han, Mingzhe</creator><creator>Qiu, Lugui</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201506</creationdate><title>Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation</title><author>Zou, Dehui ; Huang, Wenyang ; Liu, Hong ; Fu, Mingwei ; Li, Zengjun ; Sui, Weiwei ; Qi, Junyuan ; Zhao, Yaozhong ; Ru, Kun ; Han, Mingzhe ; Qiu, Lugui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-93469aae5d8cd9a0404514f3748860dca49ed61dc8764a45126c9e12f4a235243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Child</topic><topic>Female</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Humans</topic><topic>Lymphoma, Large-Cell, Anaplastic</topic><topic>Lymphoma, T-Cell, Peripheral</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>Remission Induction</topic><topic>Retrospective Studies</topic><topic>Transplantation, Autologous</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Zou, Dehui</creatorcontrib><creatorcontrib>Huang, Wenyang</creatorcontrib><creatorcontrib>Liu, Hong</creatorcontrib><creatorcontrib>Fu, Mingwei</creatorcontrib><creatorcontrib>Li, Zengjun</creatorcontrib><creatorcontrib>Sui, Weiwei</creatorcontrib><creatorcontrib>Qi, Junyuan</creatorcontrib><creatorcontrib>Zhao, Yaozhong</creatorcontrib><creatorcontrib>Ru, Kun</creatorcontrib><creatorcontrib>Han, Mingzhe</creatorcontrib><creatorcontrib>Qiu, Lugui</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Zhōnghuá xuèyèxué zázhì</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zou, Dehui</au><au>Huang, Wenyang</au><au>Liu, Hong</au><au>Fu, Mingwei</au><au>Li, Zengjun</au><au>Sui, Weiwei</au><au>Qi, Junyuan</au><au>Zhao, Yaozhong</au><au>Ru, Kun</au><au>Han, Mingzhe</au><au>Qiu, Lugui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation</atitle><jtitle>Zhōnghuá xuèyèxué zázhì</jtitle><addtitle>Zhonghua Xue Ye Xue Za Zhi</addtitle><date>2015-06</date><risdate>2015</risdate><volume>36</volume><issue>6</issue><spage>455</spage><pages>455-</pages><issn>0253-2727</issn><abstract>To investigate the outcomes of autologous stem cell transplantation (ASCT) for patients with aggressive peripheral T-cell lymphoma (PTCLs) in advanced stage.
The clinical data of 25 patients in complete remission (CR) with aggressive PTCLs received ASCT from May 1997 to June 2013 were retrospectively analyzed.
① Of the 25 cases, 16 were unspecified PTCL (PTCL-U), 4 with angioimmunoblastic T cell lymphoma (AITL), 3 with anaplastic large cell lymphoma (ALCL) and 2 with hepatosplenic T cell lymphoma (HSTL), with a median age of 30(12-54) years old. Ratio of male to female is 16∶9. The distribution of stages was 8 cases with stage Ⅲ and 17 patients with stage Ⅳ. Nine patients presented with bone marrow involvement. Before ASCT, 18 patients were in CR1 and 7 patients were in CR2. ②Two patients with HSTL in stage ⅣB and IPI score 4/5 in CR1 relapsed and died within 12 months after ASCT. At a median follow-up of 38 (range 14-110) months, the estimated 3-year probability of PFS and OS for the other 23 patients was (6</abstract><cop>China</cop><pmid>26134007</pmid><doi>10.3760/cma.j.issn.0253-2727.2015.06.002</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0253-2727 |
| ispartof | Zhōnghuá xuèyèxué zázhì, 2015-06, Vol.36 (6), p.455 |
| issn | 0253-2727 |
| language | chi |
| recordid | cdi_proquest_miscellaneous_1694965127 |
| source | MEDLINE; Free E-Journal (出版社公開部分のみ）; PubMed |
| subjects | Adolescent Adult Child Female Hematopoietic Stem Cell Transplantation Humans Lymphoma, Large-Cell, Anaplastic Lymphoma, T-Cell, Peripheral Male Middle Aged Neoplasm Staging Prognosis Remission Induction Retrospective Studies Transplantation, Autologous Young Adult |
| title | Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A03%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20analysis%20of%2025%20patients%20with%20aggressive%20peripheral%20T-cell%20lymphoma%20in%20advanced%20stage%20treated%20with%20autologous%20stem%20cell%20transplantation&rft.jtitle=Zh%C5%8Dnghu%C3%A1%20xu%C3%A8y%C3%A8xu%C3%A9%20z%C3%A1zh%C3%AC&rft.au=Zou,%20Dehui&rft.date=2015-06&rft.volume=36&rft.issue=6&rft.spage=455&rft.pages=455-&rft.issn=0253-2727&rft_id=info:doi/10.3760/cma.j.issn.0253-2727.2015.06.002&rft_dat=%3Cproquest_pubme%3E1694965127%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1694965127&rft_id=info:pmid/26134007&rfr_iscdi=true |